Cardinal Health Inc. (CAH) News
Filter CAH News Items
CAH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CAH News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest CAH News From Around the Web
Below are the latest news stories about CARDINAL HEALTH INC that investors may wish to consider to help them evaluate CAH as an investment opportunity.
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
Here's Why You Should Retain HealthEquity Stock in Your Portfolio NowHQY's sustained strength in HSAs raises optimism about the stock. |
Reasons to Retain The Cooper Companies Stock in Your Portfolio NowCOO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning. |
Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to KnowCardinal Health (CAH) closed at $122.53 in the latest trading session, marking a +0.93% move from the prior day. |
Here's Why You Should Add Glaukos Stock to Your Portfolio NowGKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism. |
Here's Why You Should Add Accuray Stock to Your Portfolio NowARAY's solid product demand and revenue growth raise optimism about the stock. |
Are You a Momentum Investor? This 1 Stock Could Be the Perfect PickWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
OPKO Health Announces Progress in EBV Vaccine Study, Stock GainsOPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases. |
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA AnalystBofA Securities predicts that headline risks affecting the Healthcare Tech & Distribution sector in 2024 will likely continue in 2025. Key areas of concern include pharmacy benefit managers (PBMs), retail pharmacies, distributors, fertility benefits, and direct-to-consumer (D2C) pharmacies. While regulatory pressure on PBMs is expected to persist, the analyst believes this will mainly impact profit margins and growth rates rather than lead to major changes in the business model. Potential policy |
Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?Investors are optimistic about GKOS' strength in its product portfolio amid robust demand and expansion in new markets. |